Vivani Medical, Inc.
$1.28
-0.78%Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
At a Glance
Live SnapshotIntrinsic Alpha Methodology
Thesis Lenses
Signal
Medium confidenceValuation multiple is compressed (P/E -3.0).
Valuation inputs: P/E -3.0, earnings yield N/A, momentum -0.8%.
If multiples stay elevated while momentum fades, downside repricing risk rises.
Driver
High confidenceReturn profile is soft (ROE -1.7%, ROIC -79.7%).
Profitability stack: net margin 0.0%, ROE -1.7%, ROIC -79.7%.
Quality deterioration often appears in margins before it shows up in headline EPS.
Risk
High confidenceRisk profile is balanced but has notable pressure points to monitor.
Risk factors: liabilities/assets +60.1%, momentum -0.8%, net margin 0.0%.
Higher leverage with weak momentum and thin margins can amplify drawdown severity.
Vivani Medical, Inc. Market vs Earnings Trajectory
Loading price and EPS data...
Vivani Medical, Inc. Fair Value Envelope
Vivani Medical, Inc. Profit Bridge
Profitability Analysis
Vivani Medical, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Strong cash conversion. Most reported earnings translate into actual cash flow, suggesting solid fundamentals.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working Capital Impact
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Vivani Medical, Inc. Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.
Debt-to-Equity Ratio
Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Balanced asset mix between current and non-current assets, typical of many stable businesses.
Vivani Medical, Inc. Street Expectations Map
No Target Data
No analyst price targets available for vani.
Vivani Medical, Inc. Insider Positioning
During the last 12 months, insiders have purchased $17.21M worth of VANI shares, with no selling activity reported.
3 Months
3.4M
4.33M
0
0.00
+4.3M
+$4.33M
3-6 Months
2.2M
3.02M
0
0.00
+3.0M
+$3.02M
6-9 Months
6.9M
9.63M
0
0.00
+9.6M
+$9.63M
9-12 Months
175.7K
223.10K
0
0.00
+223K
+$223K
Top Buyers
Williams Gregg
Director, 10 Percent Owner:
$17.01M
Mendelsohn Aaron
Director
$69K
Baker Wilford Dean
Director
$45K
Bradbury Daniel
Director
$45K
Popoff Alexandra L.
Director
$45K
Top Sellers
No selling activity
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $17.21M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Recent Trend (3 Months)
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
Insider Participation
5 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.
No Dividend Yield Data
VANI has not reported any dividend yield values in the available annual periods.
vani Dividend History
Learning Layer
Related Guides
Build conviction on VANI by pairing this stock hub with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.